UK BIOCENTRE LIMITED

07618653
Active Milton Keynes

Research and experimental development on biotechnology

148 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
U

UK BIOCENTRE LIMITED

07618653

Research and experimental development on biotechnology

Founded 3 May 2011 Active Milton Keynes, England 148 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Jun 2027 12 months remaining
Confirmation Submitted 29 May 2026 Next due 17 May 2027 11 months remaining
Net assets £8M £288K 2025 year on year
Total assets £24M £9M 2025 year on year
Total Liabilities £16M £9M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Units 2 & 3, Java Park Bradbourne Drive Tilbrook Milton Keynes MK7 8AT England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for UK BIOCENTRE LIMITED (07618653), an active life sciences and medical technology company based in Milton Keynes, England. Incorporated 3 May 2011. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Oct → 30 Sept 2025
Type full
Next accounts 30 Sept 2026
Due by 30 Jun 2027 12 months remaining

Balance Sheet & P&L (2014–2025)

Cash in Bank

£5.01M

Decreased by £1.30M (-21%)

Net Assets

£8.00M

Decreased by £287.84k (-3%)

Total Liabilities

£15.81M

Increased by £9.06M (+134%)

Turnover

£15.28M

Decreased by £5.88M (-28%)

Employees

148

Decreased by 33 (-18%)

Debt Ratio

66%

Increased by 21 (+47%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Sept Year End
2024
30 Sept Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 4

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 9,999 Shares £10k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
4 May 20119,999£10k£1

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (6)

Azenta Uk Ltd
100.0%
9,999
Emma Rooth
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Azenta Uk Ltd

Unknown

Active
Notified 4 Mar 2026
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Uk Biobank Limited

Ceased 1 Oct 2022

Ceased

Mr Simon Robert Jones

Ceased 4 Mar 2026

Ceased

Group Structure

Group Structure

UK BIOCENTRE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

2 leasehold 2 total
AddressTenurePrice PaidDate Added
Land and buildings at Osney Mead, Oxford (OX2 0AP) OXFORD
Leasehold-14 Oct 2020
Units 2 And 3, Java Park, Bradbourne Drive, Tilbrook, Milton Keynes BUCKINGHAMSHIRE
Leasehold-4 Dec 2014
Land and buildings at Osney Mead, Oxford (OX2 0AP)
Leasehold
Added 14 Oct 2020
District OXFORD
Units 2 And 3, Java Park, Bradbourne Drive, Tilbrook, Milton Keynes
Leasehold
Added 4 Dec 2014
District BUCKINGHAMSHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
10 Jun 2026CapitalCapital Cancellation Shares
10 Jun 2026CapitalCapital Return Purchase Own Shares
29 May 2026Confirmation StatementConfirmation statement made on 3 May 2026 with updates
17 Mar 2026OfficersAppointment of Andrew Mulkerin as director on 4 Mar 2026
16 Mar 2026OfficersTermination of Emma Rooth as director on 4 Mar 2026
10 Jun 2026 Capital

Capital Cancellation Shares

10 Jun 2026 Capital

Capital Return Purchase Own Shares

29 May 2026 Confirmation Statement

Confirmation statement made on 3 May 2026 with updates

17 Mar 2026 Officers

Appointment of Andrew Mulkerin as director on 4 Mar 2026

16 Mar 2026 Officers

Termination of Emma Rooth as director on 4 Mar 2026

Recent Activity

Latest Activity

Capital Cancellation Shares

6 days ago on 10 Jun 2026

Capital Return Purchase Own Shares

6 days ago on 10 Jun 2026

Confirmation statement made on 3 May 2026 with updates

2 weeks ago on 29 May 2026

Appointment of Andrew Mulkerin as director on 4 Mar 2026

3 months ago on 17 Mar 2026

Termination of Emma Rooth as director on 4 Mar 2026

3 months ago on 16 Mar 2026